Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

HBI Spotlight

 

Spanish and Portuguese hospital groups show us the future of European private healthcare — Alberto Fernandez, Healthcare Activos

Like most healthcare REITs, Healthcare Activos is primarily focused on investing in nursing homes. But since 2018 it has begun investing in hospitals as well. In a conversation with HBI, Co-CEO Alberto Fernandez explained why the largely privately funded hospitals run by Spanish and Portuguese private hospital groups are much more attractive investment prospects than the equivalents in Bismarckian countries.

MyDentist rumoured for sale amid shifting UK oral health landscape

Private equity firms Bridgepoint, Cinven, TDR Capital, and Triton Partners are reportedly among the early bidders interested in acquiring MyDentist, the UK’s largest dental chain, according to Sky News.  The current owners, Palamon Capital Partners, are hoping to fetch around £900 million, although the final deal could be closer to £800 million, the newspaper further reported.

UK REITs Assura and Care REIT both being bought out by US investors

Two of the UK’s largest listed specialist healthcare real estate investors are being bought out and taken private by US investors. Assura looks as though it is about to accept a fifth offer from US private equity firm KKR. Care REIT (formerly Impact Healthcare REIT) has accepted a takeover offer from US care home REIT CareTrust.

Innovation in healthcare and producing “Predictable Winners” — in conversation with Stuart Jackson and Ilya Trakhtenberg of L.E.K. Consulting

Stuart Jackson and Ilya Trakhtenberg of L.E.K. Consulting are on a mission to demystify the process of innovation.  In an exclusive interview ahead of their breakfast session at HBI 2025, the authors of the forthcoming book “Predictable Winners” share insights on why so many innovations fail, and how healthcare organisations can fire up what they […]

Germany’s 2025 election — what does it mean for private healthcare?

With Germany’s election results in, the healthcare landscape is rife with discussions about what lies ahead. While a number of conclusions can be drawn from these elections, the increasing polarisation of the German electorate is the most stark realisation. As a result, the Bundestag is likely to become more polarised and less willing to compromise. This expectation is further supported by speculation that the outgoing coalition and the CDU may work together to pass legislation before the new parliament convenes. Final results are to be confirmed on March 14.

What is the right financing strategy for a provider looking to scale? — in conversation with Carin Eijgenberger, Managing Director – Healthcare at ING

Capital is plentiful, but raising it is expensive, which means companies need to be strategic when considering transactions or investments. At HBI 2025, we’re hosting a panel titled “Preparing for Exit, Acquisition, or Growth: The Banker’s Perspective on Current Financing Options.”  HBI caught up with Carin Eijgenberger, Managing Director, Healthcare at ING, one of the speakers at the upcoming conference, to talk about the current financing landscape for businesses looking to exit, get acquired, or grow. With high costs despite abundant capital, we discuss how companies can stay strategic in this environment.

How Straumann is shaping the dental landscape across different markets

HBI recently hosted an oral health webinar with speakers Dr. Neil Sikka, Chief Dental Officer at Bupa Insurance, and Sara Dalmasso, Head of Enterprise Solutions at Straumann Group. The session explored the role of AI in dentistry and how to integrate it effectively, the link between oral health and general health, sustainability, and balancing clinical judgement with the use of technology. Post webinar, here HBI speaks to Dalmasso for a deeper dive on certain points (and new ones), to better understand how Straumann Group is shaping up the dental landscape and what its market learnings are.  

Finding the balance between AI and human intuition is challenging, but essential — in conversation with Betul Susamis Unaran, Ypsomed

HBI is hosting a panel in March 2025, “What is AI’s Equity Story?”, which will feature Betul Susamis Unaran as a speaker. Betul is a Board Member at Ypsomed, a Swiss-based global medtech company specialising in innovative self-care solutions, alongside her other roles in the industry.  This week, we spoke to Betul about AI’s role in healthcare, balancing technology with human intuition, how AI adoption differs between startups and established companies, along with the financial and organisational factors to consider when making AI investments.

Find Us